Caris Life Sciences, Inc. (CAI)
23.04
-0.92
(-3.84%)
USD |
NASDAQ |
Nov 13, 16:00
23.04
0.00 (0.00%)
After-Hours: 19:59
Caris Life Sciences Market Cap : 6.606B for Nov. 13, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 13, 2026 | 6.606B |
| November 12, 2026 | 6.870B |
| November 11, 2026 | 7.022B |
| November 10, 2026 | 7.005B |
| November 09, 2026 | 7.331B |
| November 06, 2026 | 7.234B |
| November 05, 2026 | 7.463B |
| November 04, 2026 | 9.525B |
| November 03, 2026 | 9.419B |
| November 02, 2026 | 9.204B |
| October 30, 2026 | 9.701B |
| October 29, 2026 | 10.21B |
| October 28, 2026 | 10.02B |
| October 27, 2026 | 9.515B |
| October 26, 2026 | 9.171B |
| October 23, 2026 | 9.043B |
| October 22, 2026 | 8.961B |
| October 21, 2026 | 9.142B |
| October 20, 2026 | 8.791B |
| October 19, 2026 | 8.678B |
| October 16, 2026 | 8.636B |
| October 15, 2026 | 8.975B |
| October 14, 2026 | 8.550B |
| October 13, 2026 | 8.345B |
| October 12, 2026 | 8.390B |
| Date | Value |
|---|---|
| October 09, 2026 | 8.393B |
| October 08, 2026 | 7.771B |
| October 07, 2026 | 7.658B |
| October 06, 2026 | 7.758B |
| October 05, 2026 | 8.588B |
| October 02, 2026 | 7.997B |
| October 01, 2026 | 8.011B |
| September 30, 2026 | 8.656B |
| September 29, 2026 | 8.915B |
| September 28, 2026 | 8.972B |
| September 25, 2026 | 9.037B |
| September 24, 2026 | 9.119B |
| September 23, 2026 | 8.944B |
| September 22, 2026 | 8.893B |
| September 21, 2026 | 8.661B |
| September 18, 2026 | 8.472B |
| September 17, 2026 | 8.737B |
| September 16, 2026 | 7.972B |
| September 15, 2026 | 8.054B |
| September 14, 2026 | 7.361B |
| September 11, 2026 | 6.878B |
| September 10, 2026 | 6.793B |
| September 09, 2026 | 6.790B |
| September 08, 2026 | 7.014B |
| September 04, 2026 | 7.084B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Natera, Inc. | 46.06B |
| Myriad Genetics, Inc. | 541.66M |
| BioRestorative Therapies, Inc. | 1.898M |
| CareDx, Inc. | 4.086B |
| Exagen, Inc. | 104.99M |
Market Cap Related Metrics
| PE Ratio | 68.21 |
| PS Ratio | 6.282 |
| Price to Book Value | 10.33 |
| Price to Free Cash Flow | 310.58 |
| Price | 23.04 |
| Earnings Yield | 1.47% |
| Operating PE Ratio | 47.05 |
| Normalized PE Ratio | 56.89 |